{
"NDC": {
"NDCCode": "67184-0573-1",
"PackageDescription": "1 VIAL in 1 CARTON (67184-0573-1) / 2 mL in 1 VIAL",
"NDC11Code": "67184-0573-01",
"ProductNDC": "67184-0573",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Olanzapine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Olanzapine",
"DosageFormName": "INJECTION, POWDER, FOR SOLUTION",
"RouteName": "INTRAMUSCULAR",
"StartMarketingDate": "20251111",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218116",
"LabelerName": "Qilu Pharmaceutical Co., Ltd.",
"SubstanceName": "OLANZAPINE",
"StrengthNumber": "10",
"StrengthUnit": "mg/2mL",
"Pharm_Classes": "Atypical Antipsychotic [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-11-12",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20251111",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}